Education
About Us
Working with TipRanks
Follow Us
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 351.37M | $ 48.63M |
| Gross Profit | $ -416.00K | $ -70.09M | $ -260.00K | $ 351.34M | $ 48.61M |
| Operating Income | $ -192.95M | $ -164.16M | $ -130.65M | $ 138.38M | $ -11.03M |
| EBITDA | $ -167.04M | $ -119.59M | $ -119.24M | $ 138.41M | $ -11.01M |
| Net Income | $ -168.38M | $ -135.96M | $ -115.91M | $ 121.19M | $ -10.95M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 454.72M | $ 578.11M | $ 646.71M | $ 764.38M | $ 850.12M |
| Total Assets | $ 464.67M | $ 594.97M | $ 666.71M | $ 772.89M | $ 863.63M |
| Total Debt | $ 1.64M | $ 2.40M | $ 3.12M | $ 197.00K | $ 0.00 |
| Net Debt | $ -63.05M | $ -141.42M | $ -643.59M | $ -764.18M | $ -850.12M |
| Total Liabilities | $ 25.80M | $ 39.78M | $ 26.14M | $ 62.81M | $ 315.83M |
| Stockholders' Equity | $ 438.87M | $ 555.19M | $ 640.57M | $ 710.08M | $ 547.80M |
| Cash Flow | |||||
| Free Cash Flow | $ -135.50M | $ -85.39M | $ -122.92M | $ -87.01M | $ 296.71M |
| Operating Cash Flow | $ -135.50M | $ -85.39M | $ -120.98M | $ -87.00M | $ 296.73M |
| Investing Cash Flow | $ 56.10M | $ 40.30M | $ -455.41M | $ -4.00K | $ -26.00K |
| Financing Cash Flow | $ 267.00K | $ 257.00K | $ 370.00K | $ 1.47M | $ 531.75M |